EGFR and gastric cancer: In a series of in vitro and in vivo experiments, Zhang et al. identified that tumour-derived EV EGFR activated liver hepatocyte growth factor (HGF) expression and release, through inhibition of mir-26 a/b expression, which promoted liver gastric cancer metastases in mice with increased size and weight compared to controls [6].